11/20
11:12 am
adag
Is Adagene (ADAG) Stock Outpacing Its Medical Peers This Year? [Yahoo! Finance]
Medium
Report
Is Adagene (ADAG) Stock Outpacing Its Medical Peers This Year? [Yahoo! Finance]
11/7
10:05 am
adag
Adagene Presents Two Posters with New Insights on Increased Therapeutic Index for Masked Anti-CTLA-4 SAFEbody® ADG126 (Muzastotug) and Data Reinforcing Clinical Safety and Efficacy for ADG126 as Monotherapy and in Combination with Anti-PD-1 Therapy at Soc
Medium
Report
Adagene Presents Two Posters with New Insights on Increased Therapeutic Index for Masked Anti-CTLA-4 SAFEbody® ADG126 (Muzastotug) and Data Reinforcing Clinical Safety and Efficacy for ADG126 as Monotherapy and in Combination with Anti-PD-1 Therapy at Soc
11/7
10:01 am
adag
Adagene Presents Two Posters with New Insights on Increased Therapeutic Index for Masked Anti-CTLA-4 SAFEbody® ADG126 (Muzastotug) and Data Reinforcing Clinical Safety and Efficacy for ADG126 as Monotherapy and in Combination with Anti-PD-1 Therapy at Soc
Medium
Report
Adagene Presents Two Posters with New Insights on Increased Therapeutic Index for Masked Anti-CTLA-4 SAFEbody® ADG126 (Muzastotug) and Data Reinforcing Clinical Safety and Efficacy for ADG126 as Monotherapy and in Combination with Anti-PD-1 Therapy at Soc
10/21
07:54 pm
adag
Adagene And 2 Other US Penny Stocks To Consider [Yahoo! Finance]
Medium
Report
Adagene And 2 Other US Penny Stocks To Consider [Yahoo! Finance]
10/9
06:00 am
adag
Adagene Announces Upcoming Poster Presentations on Masked Anti-CTLA-4 SAFEbody® ADG126 (Muzastotug) at Society for Immunotherapy of Cancer (SITC) 39th Annual Meeting
Medium
Report
Adagene Announces Upcoming Poster Presentations on Masked Anti-CTLA-4 SAFEbody® ADG126 (Muzastotug) at Society for Immunotherapy of Cancer (SITC) 39th Annual Meeting
9/27
11:22 am
adag
Is DaVita (DVA) Stock Outpacing Its Medical Peers This Year? [Yahoo! Finance]
Low
Report
Is DaVita (DVA) Stock Outpacing Its Medical Peers This Year? [Yahoo! Finance]
9/18
10:09 am
adag
Adagene Inc. (NASDAQ: ADAG) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $5.00 price target on the stock.
High
Report
Adagene Inc. (NASDAQ: ADAG) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $5.00 price target on the stock.
9/16
05:31 pm
adag
Expanding the Bispecific Antibody Market from CAR-Ts to Drive Follicular Lymphoma's Future | DelveInsight
High
Report
Expanding the Bispecific Antibody Market from CAR-Ts to Drive Follicular Lymphoma's Future | DelveInsight
9/16
05:31 pm
adag
Expanding the Bispecific Antibody Market from CAR-Ts to Drive Follicular Lymphoma's Future | DelveInsight
High
Report
Expanding the Bispecific Antibody Market from CAR-Ts to Drive Follicular Lymphoma's Future | DelveInsight
9/16
03:04 am
adag
Adagene Presents Results at ESMO Congress that Show Best-in-Class Therapeutic Potential for Anti-CTLA-4 SAFEbody® ADG126 (Muzastotug) in Combination with KEYTRUDA® (Pembrolizumab) in Advanced/Metastatic Microsatellite-stable (MSS) Colorectal Cancer (CRC)
High
Report
Adagene Presents Results at ESMO Congress that Show Best-in-Class Therapeutic Potential for Anti-CTLA-4 SAFEbody® ADG126 (Muzastotug) in Combination with KEYTRUDA® (Pembrolizumab) in Advanced/Metastatic Microsatellite-stable (MSS) Colorectal Cancer (CRC)
9/16
03:01 am
adag
Adagene Presents Results at ESMO Congress that Show Best-in-Class Therapeutic Potential for Anti-CTLA-4 SAFEbody® ADG126 (Muzastotug) in Combination with KEYTRUDA® (Pembrolizumab) in Advanced/Metastatic Microsatellite-stable (MSS) Colorectal Cancer (CRC)
High
Report
Adagene Presents Results at ESMO Congress that Show Best-in-Class Therapeutic Potential for Anti-CTLA-4 SAFEbody® ADG126 (Muzastotug) in Combination with KEYTRUDA® (Pembrolizumab) in Advanced/Metastatic Microsatellite-stable (MSS) Colorectal Cancer (CRC)
9/11
11:49 am
adag
Are Medical Stocks Lagging Adagene (ADAG) This Year? [Yahoo! Finance]
Medium
Report
Are Medical Stocks Lagging Adagene (ADAG) This Year? [Yahoo! Finance]
8/29
07:00 am
adag
Adagene to Participate in Investor Conferences in September
Low
Report
Adagene to Participate in Investor Conferences in September
8/26
10:59 am
adag
Is Adagene (ADAG) Stock Outpacing Its Medical Peers This Year? [Yahoo! Finance]
Low
Report
Is Adagene (ADAG) Stock Outpacing Its Medical Peers This Year? [Yahoo! Finance]